Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 7 de 7
Filtrer
Plus de filtres











Base de données
Gamme d'année
1.
Genes (Basel) ; 14(8)2023 07 26.
Article de Anglais | MEDLINE | ID: mdl-37628576

RÉSUMÉ

Cell proliferation and invasion are characteristic of many tumors, including ameloblastoma, and are important features to target in possible future therapeutic applications. OBJECTIVE: The objective of this study was the identification of key genes and inhibitory drugs related to the cell proliferation and invasion of ameloblastoma using bioinformatic analysis. METHODS: The H10KA_07_38 gene profile database was analyzed by Rstudio and ShinyGO Gene Ontology enrichment. String, Cytoscape-MCODE, and Kaplan-Meier plots were generated, which were subsequently validated by RT-qPCR relative expression and immunoexpression analyses. To propose specific inhibitory drugs, a bioinformatic search using Drug Gene Budger and DrugBank was performed. RESULTS: A total of 204 significantly upregulated genes were identified. Gene ontology enrichment analysis identified four pathways related to cell proliferation and cell invasion. A total of 37 genes were involved in these pathways, and 11 genes showed an MCODE score of ≥0.4; however, only SLC6A3, SOX10, and LRP5 were negatively associated with overall survival (HR = 1.49 (p = 0.0072), HR = 1.55 (p = 0.0018), and HR = 1.38 (p = 0.025), respectively). The RT-qPCR results confirmed the significant differences in expression, with overexpression of >2 for SLC6A3 and SOX10. The immunoexpression analysis indicated positive LRP5 and SLC6A3 expression. The inhibitory drugs bioinformatically obtained for the above three genes were parthenolide and vorinostat. CONCLUSIONS: We identify LRP5, SLC6A3, and SOX10 as potentially important genes related to cell proliferation and invasion in the pathogenesis of ameloblastomas, along with both parthenolide and vorinostat as inhibitory drugs that could be further investigated for the development of novel therapeutic approaches against ameloblastoma.


Sujet(s)
Améloblastome , Humains , Améloblastome/génétique , Vorinostat , Prolifération cellulaire/génétique , Biologie informatique , Facteurs de transcription SOX-E/génétique , Protéine-5 apparentée au récepteur des LDL , Transporteurs de la dopamine
2.
Biotech Histochem ; 95(8): 619-625, 2020 Nov.
Article de Anglais | MEDLINE | ID: mdl-32362205

RÉSUMÉ

Neural crest cells possess characteristics of stem cells including plasticity and ability to differentiate into various cell types. HNK1 and Sox10 are markers of neural crest cell progenitors that have been demonstrated in osteoblasts during osteogenesis of the maxilla and mandible. We investigated the presence of Sox10 and HNK1 during regeneration of mandibular bone defects. Defects were created in mandibles of rats. Samples of these defects were collected at 7, 14 and 28 days post-surgery; bone regeneration was observed during this period. Immunohistochemical analysis revealed expression of HNK1 and Sox10 in osteoblasts, osteocytes and osteogenic cells, whereas osteoclasts were unstained. HNK1 expression was increased in osteoblasts and osteocytes over time and SOX10 expression was found in osteoblasts and osteogenic cells at 7, 14 and 28 days post-surgery. HNK1 and Sox10 are present in osteoblasts, osteocytes and osteogenic cells during mandible bone regeneration.


Sujet(s)
Régénération osseuse/physiologie , Antigènes CD57/métabolisme , Facteurs de transcription SOX-E/métabolisme , Animaux , Marqueurs biologiques/métabolisme , Régulation de l'expression des gènes , Mâle , Mandibule , Ostéoblastes/métabolisme , Ostéocytes/métabolisme , Rats , Rat Wistar , Facteurs de transcription SOX-E/génétique
3.
Eur J Med Genet ; 61(6): 348-354, 2018 Jun.
Article de Anglais | MEDLINE | ID: mdl-29407415

RÉSUMÉ

This paper deals with the molecular investigation of Waardenburg syndrome (WS) in a sample of 49 clinically diagnosed probands (most from southeastern Brazil), 24 of them having the type 1 (WS1) variant (10 familial and 14 isolated cases) and 25 being affected by the type 2 (WS2) variant (five familial and 20 isolated cases). Sequential Sanger sequencing of all coding exons of PAX3, MITF, EDN3, EDNRB, SOX10 and SNAI2 genes, followed by CNV detection by MLPA of PAX3, MITF and SOX10 genes in selected cases revealed many novel pathogenic variants. Molecular screening, performed in all patients, revealed 19 causative variants (19/49 = 38.8%), six of them being large whole-exon deletions detected by MLPA, seven (four missense and three nonsense substitutions) resulting from single nucleotide substitutions (SNV), and six representing small indels. A pair of dizygotic affected female twins presented the c.430delC variant in SOX10, but the mutation, imputed to gonadal mosaicism, was not found in their unaffected parents. At least 10 novel causative mutations, described in this paper, were found in this Brazilian sample. Copy-number-variation detected by MLPA identified the causative mutation in 12.2% of our cases, corresponding to 31.6% of all causative mutations. In the majority of cases, the deletions were sporadic, since they were not present in the parents of isolated cases. Our results, as a whole, reinforce the fact that the screening of copy-number-variants by MLPA is a powerful tool to identify the molecular cause in WS patients.


Sujet(s)
Variations de nombre de copies de segment d'ADN , Mutation , Syndrome de Waardenburg/génétique , Brésil , Exons , Femelle , Prédisposition génétique à une maladie , Humains , Mâle , Mosaïcisme , Analyse de séquence d'ADN , Délétion de séquence
4.
J Cell Biochem ; 118(10): 3111-3118, 2017 10.
Article de Anglais | MEDLINE | ID: mdl-28374892

RÉSUMÉ

Astrocytes are versatile cells involved in synaptic information processing, energy metabolism, redox homeostasis, inflammatory response, and structural support of the brain. Recently, we established a routine protocol of cultured astrocytes derived from adult and aged Wistar rats, which present several different responses compared to newborn astrocytes, commonly used to characterize the role of the astrocytes in the central nervous system. Previous studies hypothesized that astrocyte cultures prepared from adult animals derive from immature precursors present in the adult tissue throughout life. Since our group has already demonstrated that the glial functionality of adult astrocytes differs from newborn cultures, the aim of this study was to confirm that our in vitro astrocytes were derived from mature cells. Therefore, we evaluated cytoskeleton proteins, such as glial fibrillary acidic protein and vimentin, as well as Sox10, an essential marker of immature glial cells, in ex vivo tissue and in in vitro astrocytes from the same animals (1, 90, and 180 days old). In addition, we examined the mitochondrial functionality and the cellular redox homeostasis. Our results suggest that adult and aged astrocytes are derived from mature cells and that changes in mitochondrial parameters in ex vivo tissue were reproduced in in vitro astrocytes. J. Cell. Biochem. 118: 3111-3118, 2017. © 2017 Wiley Periodicals, Inc.


Sujet(s)
Astrocytes/métabolisme , Cytosquelette/métabolisme , Protéine gliofibrillaire acide/métabolisme , Mitochondries/métabolisme , Facteurs de transcription SOX-E/métabolisme , Vimentine/métabolisme , Animaux , Animaux nouveau-nés , Astrocytes/cytologie , Mâle , Oxydoréduction , Rats , Rat Wistar
5.
Clin Transl Oncol ; 19(8): 1035-1044, 2017 Aug.
Article de Anglais | MEDLINE | ID: mdl-28258492

RÉSUMÉ

PURPOSE: To detect the expression level and significance of SOX10 in human bladder cancer. METHODS: Immunohistochemical analyses were performed to assess SOX10 protein level using a bladder cancer tissue microarray (including 59 spots of cancer tissues and 46 spots of paired normal tissues) and 31 specimens and to define the relationship between SOX10 and clinicopathological bladder cancer characteristics in patients. SOX10 protein and mRNA levels in bladder cancer cell lines (T24, 5637, BIU87, EJ) and transitional cell papilloma cell line (RT4) were tested by western blotting and quantitative real-time PCR (q-PCR), respectively. Cell Counting Kit-8 (CCK-8) and colony formation assays were performed to investigate bladder cancer cell proliferation after SOX10 knockdown. The effect of SOX10 on cell migration and invasion was analyzed by Transwell and Matrigel assays. Kaplan-Meier survival curves and Cox regression analyses were used to evaluate SOX10 prognostic significance for bladder cancer patients. The mechanisms by which SOX10 promote bladder cancer progression were examined by western blotting. RESULTS: SOX10 protein was upregulated in 74.4% of bladder cancer tissues compared with adjacent normal tissues (32.6%). SOX10 protein was also upregulated in malignant cell lines. In addition, high SOX10 expression was related with clinical stage (P = 0.008), T stage (P = 0.004), histological grade (P = 0.002) and lymph node metastasis (P = 0.006). Kaplan-Meier survival curves and Cox regression analyses showed that SOX10 functioned as an independent prognostic factor for overall survival. SOX10 knockdown in bladder cancer cells significantly impacted proliferation, migration and invasion, and SOX10 might promote bladder cancer progression by altering ß-catenin and Met expression. CONCLUSION: SOX10 was over-expressed in bladder cancer and promoted malignant bladder cancer cell behaviors. SOX10 has potential as a molecular target for bladder cancer treatment.


Sujet(s)
Marqueurs biologiques tumoraux/métabolisme , Carcinome transitionnel/secondaire , Régulation de l'expression des gènes tumoraux , Facteurs de transcription SOX-E/métabolisme , Tumeurs de la vessie urinaire/anatomopathologie , Sujet âgé , Marqueurs biologiques tumoraux/génétique , Carcinome transitionnel/génétique , Carcinome transitionnel/métabolisme , Études cas-témoins , Mouvement cellulaire , Prolifération cellulaire , Femelle , Études de suivi , Humains , Métastase lymphatique , Mâle , Pronostic , Facteurs de transcription SOX-E/génétique , Taux de survie , Cellules cancéreuses en culture , Tumeurs de la vessie urinaire/génétique , Tumeurs de la vessie urinaire/métabolisme
6.
Tissue Cell ; 47(5): 465-70, 2015 Oct.
Article de Anglais | MEDLINE | ID: mdl-26253417

RÉSUMÉ

Cell differentiation is essential for maxillaries and tooth development. Facial mesenchymal tissue is formed by neural crest cells (NC). These cells are highly migratory, giving rise to various cell types, considered with a high level of plasticity, indicating that they contain progenitor cells with a great power of differentiation. In this study, it was analyzed the presence of NC cell progenitors and mesenchymal stem cells (MSC) during maxillaries osteogenesis and odontogenesis in rats. Histological slides were collected in two phases: embryonic age of 15 and 17 days; 2, 4 and 7 days after birth. Immunohistochemistry for MSC markers (Osterix) and NC cells (Sox10, HNK1) was performed. The results showed positive expression for Osterix and HNK1 in undifferentiated ectomesenchymal cells in early and late stages; Sox10 was present only in early stages in undifferentiated cells. All markers were present in differentiated cells. Although the experiments performed do not allow us to explain a possible role for Osx, HNK1 and Sox10 in both differentiated and undifferentiated cells during osteogenesis and odontogenesis, it had shown important results not yet described: the presence of HNK1 and Sox10 in osteoblasts and odontoblasts in late development stages and in the tooth germ epithelial cells and ameloblasts.


Sujet(s)
Cellules souches embryonnaires/cytologie , Crête neurale/cytologie , Odontogenèse/physiologie , Ostéogenèse/physiologie , Facteurs de transcription SOX-E/métabolisme , Sulfotransferases/métabolisme , Facteurs de transcription/métabolisme , Animaux , Différenciation cellulaire/physiologie , Cellules souches mésenchymateuses/métabolisme , Odontoblastes/cytologie , Odontoblastes/métabolisme , Rat Wistar , Germe dentaire/cytologie
7.
Dev Dyn ; 243(12): 1619-31, 2014 Dec.
Article de Anglais | MEDLINE | ID: mdl-25255735

RÉSUMÉ

BACKGROUND: The peripheral olfactory sensory system arises from morphologically identifiable structures called placodes. Placodes are relatively late developing structures, evident only well after the initiation of somitogenesis. Placodes are generally described as being induced from the ectoderm suggesting that their development is separate from the coordinated cell movements generating the central nervous system. RESULTS: With the advent of modern techniques it is possible to follow the development of the neurectoderm giving rise to the anterior neural tube, including the olfactory placodes. The cell movements giving rise to the optic cup are coordinated with those generating the olfactory placodes and adjacent telencephalon. The formation of the basal lamina separating the placode from the neural tube is coincident with the anterior migration of cranial neural crest. CONCLUSIONS: Olfactory placodes are transient morphological structures arising from a continuous sheet of neurectoderm that gives rise to the peripheral and central nervous system. This field of cells is specified at the end of gastrulation and not secondarily induced from ectoderm. The separation of olfactory placodes and telencephalon occurs through complex cell movements within the developing neural plate similar to that observed for the developing optic cup.


Sujet(s)
Plaque neurale/embryologie , Tube neural/embryologie , Bulbe olfactif/embryologie , Organogenèse/physiologie , Danio zébré/embryologie , Animaux , Plaque neurale/cytologie , Tube neural/cytologie , Bulbe olfactif/cytologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE